双重作用的SIRT7抑制由奥洛林A重编程HSCs命运:PRMT5顺化驱动的衰老和Ecto-Calreticulin依赖的NK细胞免疫清除在肝纤维化
Junrui Wang1, Haoyuan Tian1, Yuanyuan Gao1
1Jiangsu Key Laboratory for Pharmacology and Safety Research of Chinese Materia Media, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Research (Washington, D.C.)
|August 8, 2025
概括
奥洛西林A (OA) 向Sirtuin 7 (SIRT7) 通过促进肝星细胞 (HSC) 衰老和NK细胞清除来抑制肝纤维化. 这种双重作用使SIRT7成为肝脏疾病的关键治疗点.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 肝星细胞 (HSC) 的激活是肝脏纤维化过程的核心.
- 向激活的HSC为肝纤维化提供了一个有前途的治疗途径.
- 调控HSC激活和清除的分子机制需要进一步阐明.
研究的目的:
- 调查奥洛西林A (OA) 抑制HSC激活的机制.
- 为了确定Sirtuin 7 (SIRT7) 在OA介导的抗纤维素作用中的作用.
- 阐明OA治疗作用中涉及的双重调节途径.
主要方法:
- 单细胞转录组测序和生物信息学分析.
- 分子测定包括西式涂抹,免疫光和共同免疫沉.
- 在人体样本,动物模型和初级HSC培养物中进行验证.
主要成果:
- 通过准SIRT7.7,OA抑制了HSC的激活.
- 甲酸通过化触发PRMT5降解,导致cGAS-STING通路激活和HSC衰老.
- 氨酸通过ecto-CRT上调来增强NK细胞介导的HSC清除,独立于SIRT7脱酶活性.
结论:
- 氨酸通过一种涉及SIRT7抑制的双重机制发挥抗纤维素作用.
- 这种机制协调HSC衰老和免疫清除,突出SIRT7作为治疗点.
- 这些发现为开发针对SIRT7.7的新型抗纤维菌策略提供了机制性见解.
更多相关视频
12:12In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Published on: December 17, 2013
12.7K
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.4K
相关概念视频
Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
